TG Investment Ltd. has made a significant move in its investment portfolio by acquiring 7% of OpGen, Inc.’s outstanding common stock. This transaction was initiated on August 23, 2024, when TG Investment Ltd. purchased 263,961 shares of OpGen’s Series E Convertible Preferred Stock. Shortly after, On August 27, 2024, these shares were converted into 633,506 shares of common stock, positioning TG Investment Ltd. as a significant shareholder.
With 10,068,111 shares of OpGen’s common stock outstanding as of September 19, 2024, TG Investment’s newly acquired stake reflects its confidence in OpGen’s potential for growth.
OpGen, Inc. with its stock listed on the NASDAQ (ticker: OPGN). Moreover, OpGen’s stock price is also quoted on the London, Berlin, and Munich stock exchanges, broadening its visibility and liquidity in international markets.
TG Investment Ltd., through this investment, reinforces its strategy of aligning with high-potential companies in cutting-edge industries. The decision to convert the preferred stock into common shares highlights a long-term commitment to OpGen, though TG Investment has stated that the acquisition is not intended to influence the control of the company.
As part of its reporting obligations, TG Investment Ltd. filed a Schedule 13G with the SEC, which confirms the details of this transaction and their beneficial ownership status.
This move not only highlights TG Investment’s strategic to diversify their investment portfolio with promising ventures in the rapidly but also demonstrates its intent to diversify across key international stock exchanges, including NASDAQ, London, Berlin, and Munich
SEC FILING: https://www.sec.gov/Archives/edgar/data/1293818/000203687224000002/xslSCHEDULE_13G_X01/primary_doc.xml